California’s Medicaid pharmacy “carve-out” set to boost state’s negotiating power, introduce IRP for drugs
California is planning a major overhaul of its Medicaid Pharmacy benefit, called Medi-Cal Rx, that will result in a "carve-out"…
Pricing and reimbursement
-
-
Germany’s ESG Law: A case study for new pharma pricing model
Pharmaceutical pricing is increasingly becoming a broader topic in the global push towards sustainability and environmental, social, and government (ESG)…
-
Reimbursement outcomes for combination therapies in breast cancer
Combination therapies are particularly common in breast cancer. Data from our PharmOnline International (POLI) database indicate that combination therapies account for 70.3%…
-
Why are pharma prices changing?
Understanding the reasons behind medicines' price changes has been a common challenge Prices of medicines evolve over time and are…
-
Japan’s new CEA-based price adjustments set to maintain pricing pressure on innovative drugs
Over the past several years, Japan - which reimburses 99% of all medicines approved in the country - has introduced…
-
US drug prices rise over 4% in 2021 reversing multi-year trend of slowed growth
Usually in January, every year, a large number of pharmaceutical companies update product prices - a trend that often receives…
